Neglected rare disease patients offered hope in new plan
Unmet need among over 7000 rare diseases is being addressed in a comprehensive action plan
Read More
Author: John Pinching
CHMP provides initial assessment of Valneva’s COVID-19 vaccine
Valneva expects to receive a positive CHMP recommendation for the conditional approval of its VLA2001 vaccine
Read More
Community pharmacies save 20,000 lives during initial vaccination phases
Figures by National Audit Office estimate that programme prevented up to 262,000 hospitalisations
Read More
Data from first DMT-assisted clinical trial revealed
No sign of significant negative effects on anxiety and wellbeing following pioneering Small Pharma trial
Read More
Data delivery: Sanofi and GSK seek authorisation for COVID-19 vaccine
Pharma giants take major stride as vaccine shows significant increase in neutralising antibodies
Read More- Transgene completes randomisation in phase 2 trial of tg4050
- Bayer wins MHRA approval for Kerendia in heart failure
- Oxford BioTherapeutics signs collaboration with Bristol Myers Squibb
- Kainova expands DT 7012 trial into Europe
- Amgen reports positive phase 3 results for subcutaneous TEPEZZA in thyroid eye disease
